Skip to main content
All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for INFECTIOUS DISEASES SOCIETY OF AMERICA · Medical association promoting public health and prevention of infectious diseases

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate · $50,000.00 income · posted Jul 21, 2025

Official filing document

 Bills named in this filing 3
  • HCONRES 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…
  • SCONRES 7
    An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal ye…
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 3
Medical/Disease Research/Clinical Labs

Legislation related to anti-microbial resistance generally

Budget/Appropriations

Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally Reauthorization of Bio-Preparedness Workforce Pilot Program H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally

Medicare/Medicaid

Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem